Woman Claims Pregnancy While Using Mounjaro, Husband on Ozempic Led to Long-Awaited Baby
A woman's experience with Mounjaro and her husband's use of Ozempic during their struggle with infertility has led to a successful pregnancy, prompting speculation about the drugs' potential effects beyond their approved uses.
A woman's journey through five years of infertility has culminated in a pregnancy, which she attributes, in part, to her use of Mounjaro and her husband's concurrent use of Ozempic. The experience has led her to believe these medications may have played a role in overcoming her long-standing fertility challenges.
Rhiannon Picton-James, the author of the account, shared that she became pregnant while using Mounjaro, a medication primarily prescribed for type 2 diabetes and weight management. Concurrently, her husband was using Ozempic, another medication commonly used for type 2 diabetes and weight loss. Picton-James expressed her conviction that these treatments were instrumental in achieving the pregnancy she had long desired.
After the birth of her first child, Ada, when she was 28, Picton-James stated she spent years in denial about her perceived inability to conceive again. The positive pregnancy test in April, after she began using Mounjaro in January, brought both joy and concern.
Mounjaro (tirzepatide) and Ozempic (semaglutide) are both GLP-1 receptor agonists that have gained significant attention for their effectiveness in weight management. While approved for type 2 diabetes management, Ozempic has also seen widespread off-label use for weight loss. Mounjaro is approved for type 2 diabetes in the U.S. and is under review for weight management. Neither drug is currently approved by the FDA for the treatment of infertility. However, anecdotal reports and ongoing research explore potential indirect benefits or correlations with reproductive health outcomes in individuals using these medications for other conditions.